首页> 外文期刊>JNCI: Journal of the National Cancer Institute >CYP2D6 Genotype as a Marker for Benefit of Adjuvant Tamoxifen in Postmenopausal Women: Lessons Learned

【24h】

CYP2D6 Genotype as a Marker for Benefit of Adjuvant Tamoxifen in Postmenopausal Women: Lessons Learned

机译：CYP2D6基因型作为绝经后妇女辅助用他莫昔芬获益的标志物：经验教训

获取原文

获取原文并翻译 | 示例

开具论文收录证明 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《JNCI: Journal of the National Cancer Institute》 |2012年第6期|p.427-428|共2页
作者
Kathleen I. Pritchard;
展开▼
作者单位

Catherine M. Kelly, MD, MSc, Department of Medical Oncology, Mater Misericordiae University Hospital, 36 Eccles St, Dublin 7, Ireland (e-mail:;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. CYP2D6 genotype as a marker for benefit of adjuvant tamoxifen in postmenopausal women: Lessons learned [J] . KellyC.M., PritchardK.I. Journal of the National Cancer Institute . 2012,第6期

机译：CYP2D6基因型作为替莫昔芬在绝经后妇女中获益的标志物：经验教训
2. Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial and Re: CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients [J] . Paul D. P. Pharoah Jean Abraham and Carlos Caldas Journal of the National Cancer Institute . 2012,第16期

机译：Re：CYP2D6基因型和他莫昔芬对内分泌反应性乳腺癌的绝经后妇女的反应：国际乳腺癌组织1-98试验和Re：CYP2D6和UGT2B7基因型与他莫昔芬治疗的乳腺癌患者的复发风险
3. Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients [J] . PharoahP.D.P., AbrahamJ., CaldasC. Journal of the National Cancer Institute . 2012,第16期

机译：Re：CYP2D6基因型和他莫昔芬反应对绝经后内分泌反应性乳腺癌妇女的影响：乳腺癌国际组1-98试验和Re：CYP2D6和UGT2B7基因型与他莫昔芬治疗的乳腺癌患者的复发风险
4. Study on the Efficacy Evaluation of Oral Sequential Tamoxifen in Postmenopausal Women with Hormone-dependent Breast Cancer [C] . Na Li, Yahua Sun, Sheng Zhao, International Conference on Life Sciences, Medicine, and Health . 2018

机译：激素依赖性乳腺癌后代妇女口腔序列儿毒素疗效评价研究
5. Understanding Hiking Participation and Benefits: Lessons Learned from the First Day Hikes Initiative [D] . Wilcer, Sarah R. 2017

机译：了解远足参与和收益：从“一日远足计划”中吸取的教训
6. CYP2D6 genotypes endoxifen levels and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer [O] . Richard R Love, Zuerenesay Desta, David Flockhart, -1

机译：CYP2D6基因型内啡肽水平和疾病复发在224例接受他莫昔芬辅助治疗可手术性乳腺癌的菲律宾和越南妇女中
7. Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial and Re: CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients [O] . P. D. P. Pharoah, J. Abraham, C. Caldas 2012

机译：Re：Cyp2D6基因型和三种毒素反应患有内分泌响应乳腺癌的绝经后妇女：乳房国际组1-98试验和RE：CYP2D6和UGT2B7基因型和制革治疗乳腺癌患者的复发风险

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号